{
    "abstract": "The first evidence in humans that a safe and effective preventive vaccine for HIV is possible came from the phase III HIV clinical trial RV144 in Thailand. This trial was based on a prime/boost combination of a recombinant canarypox vaccine and two glycoprotein 120 proteins (ALVAC-HIV and AIDSVAX B/E). A pivotal phase IIb/III trial has recently commenced in the Republic of South Africa, for which the infectious titer assay was applied as the quantitative release test for the ALVAC-HIV vaccine. The infectious titer assay measures the ability of the vaccine vector to infect target permissive cells, but does not indicate if the vaccine transgenes are expressed. We have developed a high-throughput biological activity assay that provides results in agreement with the infectious titer assay. This assay uses flow cytometry to quantify expression of ALVAC-HIV encoded proteins gp120 and p24 in human cells. This transgene expression is detected by two cross-clade-reactive, biologically functional human anti-gp120 monoclonal antibodies isolated from clinical trial participants and a commercial mouse anti-p24 monoclonal antibody. The relative biological activity of the vaccine test sample is calculated by comparison of the test sample dose-response curve against that of a reference standard. We show that the novel biological activity assay is specific, accurate, precise, stability-indicating, and robust. The assay is being used for characterization of ALVAC-HIV (vCP2438) product, the efficacy of which is being evaluated in the pivotal phase IIb/III clinical trial HVTN702. The biological activity assay has the potential to indicate vaccine consistency and quality as a complement to the infectious titer assay.",
    "author_highlights": [
        {
            "endOffset": 15098,
            "sentence": "High-throughput biological activity assay for characterization of ALVAC-HIV vaccine.",
            "startOffset": 15014
        },
        {
            "endOffset": 15184,
            "sentence": "Results correlate with infectious titer assay, the vaccine quantitative release test.",
            "startOffset": 15099
        },
        {
            "endOffset": 15256,
            "sentence": "Assay is specific, accurate, precise, stability-indicating, and robust.",
            "startOffset": 15185
        },
        {
            "endOffset": 15329,
            "sentence": "Utilizes biologically functional human anti-gp120 monoclonal antibodies.",
            "startOffset": 15257
        },
        {
            "endOffset": 15402,
            "sentence": "Used for characterization of ALVAC-HIV vaccine in pivotal HVTN702 study.",
            "startOffset": 15330
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Jaranit",
                    "initial": "J.",
                    "last": "Kaewkungwal"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Chiu"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Paris"
                },
                {
                    "first": "Nakorn",
                    "initial": "N.",
                    "last": "Premsri"
                },
                {
                    "first": "Chawetsan",
                    "initial": "C.",
                    "last": "Namwat"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "De Souza"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Adams"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Benenson"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Gurunathan"
                },
                {
                    "first": "Jim",
                    "initial": "J.",
                    "last": "Tartaglia"
                },
                {
                    "first": "John G.",
                    "initial": "J.G.",
                    "last": "McNeil"
                },
                {
                    "first": "Donald P.",
                    "initial": "D.P.",
                    "last": "Francis"
                },
                {
                    "first": "Donald",
                    "initial": "D.",
                    "last": "Stablein"
                },
                {
                    "first": "Deborah L.",
                    "initial": "D.L.",
                    "last": "Birx"
                },
                {
                    "first": "Supamit",
                    "initial": "S.",
                    "last": "Chunsuttiwat"
                },
                {
                    "first": "Chirasak",
                    "initial": "C.",
                    "last": "Khamboonruang"
                },
                {
                    "first": "Prasert",
                    "initial": "P.",
                    "last": "Thongcharoen"
                },
                {
                    "first": "Merlin L.",
                    "initial": "M.L.",
                    "last": "Robb"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "Prayura",
                    "initial": "P.",
                    "last": "Kunasol"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                }
            ],
            "doi": "10.1056/NEJMoa0908492",
            "firstpage": "2209",
            "issn": "00284793",
            "lastpage": "2220",
            "pmid": "19843557",
            "pub_year": 2009,
            "title": "Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand",
            "volume": "361"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Linda Gail",
                    "initial": "L.G.",
                    "last": "Bekker"
                },
                {
                    "first": "Glenda E.",
                    "initial": "G.E.",
                    "last": "Gray"
                }
            ],
            "doi": "10.1371/journal.pmed.1002241",
            "issn": "15491277",
            "pmid": "28245236",
            "pub_year": 2017,
            "title": "Hope for HIV control in southern Africa: The continued quest for a vaccine",
            "volume": "14"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Nina D.",
                    "initial": "N.D.",
                    "last": "Russell"
                },
                {
                    "first": "Mary A.",
                    "initial": "M.A.",
                    "last": "Marovich"
                }
            ],
            "doi": "10.1097/COH.0000000000000322",
            "firstpage": "614",
            "issn": "1746630X",
            "lastpage": "619",
            "pmid": "27636503",
            "pub_year": 2016,
            "title": "Pox-Protein Public Private Partnership program and upcoming HIV vaccine efficacy trials",
            "volume": "11"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "Gilbert"
                },
                {
                    "first": "M. Juliana",
                    "initial": "M.J.",
                    "last": "McElrath"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Zolla-Pazner"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                },
                {
                    "first": "S. Munir",
                    "initial": "S.M.",
                    "last": "Alam"
                },
                {
                    "first": "David T.",
                    "initial": "D.T.",
                    "last": "Evans"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Montefiori"
                },
                {
                    "first": "Chitraporn",
                    "initial": "C.",
                    "last": "Karnasuta"
                },
                {
                    "first": "Ruengpueng",
                    "initial": "R.",
                    "last": "Sutthent"
                },
                {
                    "first": "Hua Xin",
                    "initial": "H.X.",
                    "last": "Liao"
                },
                {
                    "first": "Anthony L.",
                    "initial": "A.L.",
                    "last": "DeVico"
                },
                {
                    "first": "George K.",
                    "initial": "G.K.",
                    "last": "Lewis"
                },
                {
                    "first": "Constance",
                    "initial": "C.",
                    "last": "Williams"
                },
                {
                    "first": "Abraham",
                    "initial": "A.",
                    "last": "Pinter"
                },
                {
                    "first": "Youyi",
                    "initial": "Y.",
                    "last": "Fong"
                },
                {
                    "first": "Holly",
                    "initial": "H.",
                    "last": "Janes"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "DeCamp"
                },
                {
                    "first": "Yunda",
                    "initial": "Y.",
                    "last": "Huang"
                },
                {
                    "first": "Mangala",
                    "initial": "M.",
                    "last": "Rao"
                },
                {
                    "first": "Erik",
                    "initial": "E.",
                    "last": "Billings"
                },
                {
                    "first": "Nicos",
                    "initial": "N.",
                    "last": "Karasavvas"
                },
                {
                    "first": "Merlin L.",
                    "initial": "M.L.",
                    "last": "Robb"
                },
                {
                    "first": "Viseth",
                    "initial": "V.",
                    "last": "Ngauy"
                },
                {
                    "first": "Mark S.",
                    "initial": "M.S.",
                    "last": "De Souza"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Paris"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Ferrari"
                },
                {
                    "first": "Robert T.",
                    "initial": "R.T.",
                    "last": "Bailer"
                },
                {
                    "first": "Kelly A.",
                    "initial": "K.A.",
                    "last": "Soderberg"
                },
                {
                    "first": "Charla",
                    "initial": "C.",
                    "last": "Andrews"
                },
                {
                    "first": "Phillip W.",
                    "initial": "P.W.",
                    "last": "Berman"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Frahm"
                },
                {
                    "first": "Stephen C.",
                    "initial": "S.C.",
                    "last": "De Rosa"
                },
                {
                    "first": "Michael D.",
                    "initial": "M.D.",
                    "last": "Alpert"
                },
                {
                    "first": "Nicole L.",
                    "initial": "N.L.",
                    "last": "Yates"
                },
                {
                    "first": "Xiaoying",
                    "initial": "X.",
                    "last": "Shen"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Koup"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "Jaranit",
                    "initial": "J.",
                    "last": "Kaewkungwal"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                }
            ],
            "doi": "10.1056/NEJMoa1113425",
            "firstpage": "1275",
            "issn": "00284793",
            "lastpage": "1286",
            "pub_year": 2012,
            "title": "Immune-correlates analysis of an HIV-1 vaccine efficacy trial",
            "volume": "366"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Nicole L.",
                    "initial": "N.L.",
                    "last": "Yates"
                },
                {
                    "first": "Hua Xin",
                    "initial": "H.X.",
                    "last": "Liao"
                },
                {
                    "first": "Youyi",
                    "initial": "Y.",
                    "last": "Fong"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "DeCamp"
                },
                {
                    "first": "Nathan A.",
                    "initial": "N.A.",
                    "last": "Vandergrift"
                },
                {
                    "first": "William T.",
                    "initial": "W.T.",
                    "last": "Williams"
                },
                {
                    "first": "S. Munir",
                    "initial": "S.M.",
                    "last": "Alam"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Ferrari"
                },
                {
                    "first": "Zhi Yong",
                    "initial": "Z.Y.",
                    "last": "Yang"
                },
                {
                    "first": "Kelly E.",
                    "initial": "K.E.",
                    "last": "Seaton"
                },
                {
                    "first": "Phillip W.",
                    "initial": "P.W.",
                    "last": "Berman"
                },
                {
                    "first": "Michael D.",
                    "initial": "M.D.",
                    "last": "Alpert"
                },
                {
                    "first": "David T.",
                    "initial": "D.T.",
                    "last": "Evans"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "O'Connell"
                },
                {
                    "first": "Donald",
                    "initial": "D.",
                    "last": "Francis"
                },
                {
                    "first": "Faruk",
                    "initial": "F.",
                    "last": "Sinangil"
                },
                {
                    "first": "Carter",
                    "initial": "C.",
                    "last": "Lee"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Jaranit",
                    "initial": "J.",
                    "last": "Kaewkungwal"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Tartaglia"
                },
                {
                    "first": "Abraham",
                    "initial": "A.",
                    "last": "Pinter"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Zolla-Pazner"
                },
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "Gilbert"
                },
                {
                    "first": "Gary J.",
                    "initial": "G.J.",
                    "last": "Nabel"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Montefiori"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                }
            ],
            "doi": "10.1126/scitranslmed.3007730",
            "issn": "19466234",
            "pmid": "24648342",
            "pub_year": 2014,
            "title": "Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination",
            "volume": "6"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Lawrence",
                    "initial": "L.",
                    "last": "Corey"
                },
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "Gilbert"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Pantaleo"
                },
                {
                    "first": "Anthony S.",
                    "initial": "A.S.",
                    "last": "Fauci"
                }
            ],
            "doi": "10.1126/scitranslmed.aac7732",
            "issn": "19466234",
            "pmid": "26491081",
            "pub_year": 2015,
            "title": "Immune correlates of vaccine protection against HIV-1 acquisition",
            "volume": "7"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Raphael",
                    "initial": "R.",
                    "last": "Gottardo"
                },
                {
                    "first": "Robert T.",
                    "initial": "R.T.",
                    "last": "Bailer"
                },
                {
                    "first": "Bette T.",
                    "initial": "B.T.",
                    "last": "Korber"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Gnanakaran"
                },
                {
                    "first": "Joshua",
                    "initial": "J.",
                    "last": "Phillips"
                },
                {
                    "first": "Xiaoying",
                    "initial": "X.",
                    "last": "Shen"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                },
                {
                    "first": "Ellen",
                    "initial": "E.",
                    "last": "Turk"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Imholte"
                },
                {
                    "first": "Larry",
                    "initial": "L.",
                    "last": "Eckler"
                },
                {
                    "first": "Holger",
                    "initial": "H.",
                    "last": "Wenschuh"
                },
                {
                    "first": "Johannes",
                    "initial": "J.",
                    "last": "Zerweck"
                },
                {
                    "first": "Kelli",
                    "initial": "K.",
                    "last": "Greene"
                },
                {
                    "first": "Hongmei",
                    "initial": "H.",
                    "last": "Gao"
                },
                {
                    "first": "Phillip W.",
                    "initial": "P.W.",
                    "last": "Berman"
                },
                {
                    "first": "Donald",
                    "initial": "D.",
                    "last": "Francis"
                },
                {
                    "first": "Faruk",
                    "initial": "F.",
                    "last": "Sinangil"
                },
                {
                    "first": "Carter",
                    "initial": "C.",
                    "last": "Lee"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Jaranit",
                    "initial": "J.",
                    "last": "Kaewkungwal"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Tartaglia"
                },
                {
                    "first": "Merlin L.",
                    "initial": "M.L.",
                    "last": "Robb"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Zolla-Pazner"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Mascola"
                },
                {
                    "first": "Steve",
                    "initial": "S.",
                    "last": "Self"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Gilbert"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Montefiori"
                }
            ],
            "doi": "10.1371/journal.pone.0075665",
            "issn": "19326203",
            "pmid": "24086607",
            "pub_year": 2013,
            "title": "Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial",
            "volume": "8"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Mattia",
                    "initial": "M.",
                    "last": "Bonsignori"
                },
                {
                    "first": "Justin",
                    "initial": "J.",
                    "last": "Pollara"
                },
                {
                    "first": "Anthony A.",
                    "initial": "A.A.",
                    "last": "Moody"
                },
                {
                    "first": "Xi",
                    "initial": "X.",
                    "last": "Chen"
                },
                {
                    "first": "Kwan Ki",
                    "initial": "K.K.",
                    "last": "Hwang"
                },
                {
                    "first": "Thaddeus C.",
                    "initial": "T.C.",
                    "last": "Gurley"
                },
                {
                    "first": "Daniel M.",
                    "initial": "D.M.",
                    "last": "Kozink"
                },
                {
                    "first": "Dawn J.",
                    "initial": "D.J.",
                    "last": "Marshall"
                },
                {
                    "first": "John F.",
                    "initial": "J.F.",
                    "last": "Whitesides"
                },
                {
                    "first": "Chun Yen",
                    "initial": "C.Y.",
                    "last": "Tsao"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Montefiori"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Ferrari"
                },
                {
                    "first": "Hua Xin",
                    "initial": "H.X.",
                    "last": "Liao"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "Michael D.",
                    "initial": "M.D.",
                    "last": "Alpert"
                },
                {
                    "first": "David T.",
                    "initial": "D.T.",
                    "last": "Evans"
                },
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "Gilbert"
                },
                {
                    "first": "Ying",
                    "initial": "Y.",
                    "last": "Huang"
                },
                {
                    "first": "Jaranit",
                    "initial": "J.",
                    "last": "Kaewkungwal"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "George K.",
                    "initial": "G.K.",
                    "last": "Lewis"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "DeVico"
                }
            ],
            "doi": "10.1128/JVI.01023-12",
            "firstpage": "11521",
            "issn": "0022538X",
            "lastpage": "11532",
            "pmid": "22896626",
            "pub_year": 2012,
            "title": "Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family",
            "volume": "86"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Hua Xin",
                    "initial": "H.X.",
                    "last": "Liao"
                },
                {
                    "first": "Mattia",
                    "initial": "M.",
                    "last": "Bonsignori"
                },
                {
                    "first": "S. Munir",
                    "initial": "S.M.",
                    "last": "Alam"
                },
                {
                    "first": "Jason S.",
                    "initial": "J.S.",
                    "last": "McLellan"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                },
                {
                    "first": "M. Anthony",
                    "initial": "M.A.",
                    "last": "Moody"
                },
                {
                    "first": "Daniel M.",
                    "initial": "D.M.",
                    "last": "Kozink"
                },
                {
                    "first": "Kwan Ki",
                    "initial": "K.K.",
                    "last": "Hwang"
                },
                {
                    "first": "Xi",
                    "initial": "X.",
                    "last": "Chen"
                },
                {
                    "first": "Chun Yen",
                    "initial": "C.Y.",
                    "last": "Tsao"
                },
                {
                    "first": "Pinghuang",
                    "initial": "P.",
                    "last": "Liu"
                },
                {
                    "first": "Xiaozhi",
                    "initial": "X.",
                    "last": "Lu"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Parks"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Montefiori"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Ferrari"
                },
                {
                    "first": "Justin",
                    "initial": "J.",
                    "last": "Pollara"
                },
                {
                    "first": "Mangala",
                    "initial": "M.",
                    "last": "Rao"
                },
                {
                    "first": "Kristina K.",
                    "initial": "K.K.",
                    "last": "Peachman"
                },
                {
                    "first": "Sampa",
                    "initial": "S.",
                    "last": "Santra"
                },
                {
                    "first": "Norman L.",
                    "initial": "N.L.",
                    "last": "Letvin"
                },
                {
                    "first": "Nicos",
                    "initial": "N.",
                    "last": "Karasavvas"
                },
                {
                    "first": "Zhi Yong",
                    "initial": "Z.Y.",
                    "last": "Yang"
                },
                {
                    "first": "Kaifan",
                    "initial": "K.",
                    "last": "Dai"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Pancera"
                },
                {
                    "first": "Jason",
                    "initial": "J.",
                    "last": "Gorman"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Wiehe"
                },
                {
                    "first": "Nathan I.",
                    "initial": "N.I.",
                    "last": "Nicely"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Jaranit",
                    "initial": "J.",
                    "last": "Kaewkungwal"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Tartaglia"
                },
                {
                    "first": "Faruk",
                    "initial": "F.",
                    "last": "Sinangil"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "Thomas B.",
                    "initial": "T.B.",
                    "last": "Kepler"
                },
                {
                    "first": "Peter D.",
                    "initial": "P.D.",
                    "last": "Kwong"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Mascola"
                },
                {
                    "first": "Gary J.",
                    "initial": "G.J.",
                    "last": "Nabel"
                },
                {
                    "first": "Abraham",
                    "initial": "A.",
                    "last": "Pinter"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Zolla-Pazner"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                }
            ],
            "doi": "10.1016/j.immuni.2012.11.011",
            "firstpage": "176",
            "issn": "10747613",
            "lastpage": "186",
            "pmid": "23313589",
            "pub_year": 2013,
            "title": "Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2",
            "volume": "38"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Zolla-Pazner"
                },
                {
                    "first": "Allan",
                    "initial": "A.",
                    "last": "DeCamp"
                },
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "Gilbert"
                },
                {
                    "first": "Constance",
                    "initial": "C.",
                    "last": "Williams"
                },
                {
                    "first": "Nicole L.",
                    "initial": "N.L.",
                    "last": "Yates"
                },
                {
                    "first": "William T.",
                    "initial": "W.T.",
                    "last": "Williams"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Howington"
                },
                {
                    "first": "Youyi",
                    "initial": "Y.",
                    "last": "Fong"
                },
                {
                    "first": "Daryl E.",
                    "initial": "D.E.",
                    "last": "Morris"
                },
                {
                    "first": "Kelly A.",
                    "initial": "K.A.",
                    "last": "Soderberg"
                },
                {
                    "first": "Carmela",
                    "initial": "C.",
                    "last": "Irene"
                },
                {
                    "first": "Charles",
                    "initial": "C.",
                    "last": "Reichman"
                },
                {
                    "first": "Abraham",
                    "initial": "A.",
                    "last": "Pinter"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Parks"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "Jaranit",
                    "initial": "J.",
                    "last": "Kaewkungwal"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Charla",
                    "initial": "C.",
                    "last": "Andrews"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "O'Connell"
                },
                {
                    "first": "Zhi Yong",
                    "initial": "Z.Y.",
                    "last": "Yang"
                },
                {
                    "first": "Gary J.",
                    "initial": "G.J.",
                    "last": "Nabel"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Montefiori"
                },
                {
                    "first": "Hua Xin",
                    "initial": "H.X.",
                    "last": "Liao"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                }
            ],
            "doi": "10.1371/journal.pone.0087572",
            "issn": "19326203",
            "pmid": "24504509",
            "pub_year": 2014,
            "title": "Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection",
            "volume": "9"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Zolla-Pazner"
                },
                {
                    "first": "Allan C.",
                    "initial": "A.C.",
                    "last": "deCamp"
                },
                {
                    "first": "Timothy",
                    "initial": "T.",
                    "last": "Cardozo"
                },
                {
                    "first": "Nicos",
                    "initial": "N.",
                    "last": "Karasavvas"
                },
                {
                    "first": "Raphael",
                    "initial": "R.",
                    "last": "Gottardo"
                },
                {
                    "first": "Constance",
                    "initial": "C.",
                    "last": "Williams"
                },
                {
                    "first": "Daryl E.",
                    "initial": "D.E.",
                    "last": "Morris"
                },
                {
                    "first": "Georgia",
                    "initial": "G.",
                    "last": "Tomaras"
                },
                {
                    "first": "Mangala",
                    "initial": "M.",
                    "last": "Rao"
                },
                {
                    "first": "Erik",
                    "initial": "E.",
                    "last": "Billings"
                },
                {
                    "first": "Phillip",
                    "initial": "P.",
                    "last": "Berman"
                },
                {
                    "first": "Xiaoying",
                    "initial": "X.",
                    "last": "Shen"
                },
                {
                    "first": "Charla",
                    "initial": "C.",
                    "last": "Andrews"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "O'Connell"
                },
                {
                    "first": "Viseth",
                    "initial": "V.",
                    "last": "Ngauy"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "de Souza"
                },
                {
                    "first": "Bette",
                    "initial": "B.",
                    "last": "Korber"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Koup"
                },
                {
                    "first": "Robert T.",
                    "initial": "R.T.",
                    "last": "Bailer"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Mascola"
                },
                {
                    "first": "Abraham",
                    "initial": "A.",
                    "last": "Pinter"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Montefiori"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "Merlin L.",
                    "initial": "M.L.",
                    "last": "Robb"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "Gilbert"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                }
            ],
            "doi": "10.1371/journal.pone.0053629",
            "issn": "19326203",
            "pmid": "23349725",
            "pub_year": 2013,
            "title": "Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial",
            "volume": "8"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Mattia",
                    "initial": "M.",
                    "last": "Bonsignori"
                },
                {
                    "first": "Kwan Ki",
                    "initial": "K.K.",
                    "last": "Hwang"
                },
                {
                    "first": "Xi",
                    "initial": "X.",
                    "last": "Chen"
                },
                {
                    "first": "Chun Yen",
                    "initial": "C.Y.",
                    "last": "Tsao"
                },
                {
                    "first": "Lynn",
                    "initial": "L.",
                    "last": "Morris"
                },
                {
                    "first": "Elin",
                    "initial": "E.",
                    "last": "Gray"
                },
                {
                    "first": "Dawn J.",
                    "initial": "D.J.",
                    "last": "Marshall"
                },
                {
                    "first": "John A.",
                    "initial": "J.A.",
                    "last": "Crump"
                },
                {
                    "first": "Saidi H.",
                    "initial": "S.H.",
                    "last": "Kapiga"
                },
                {
                    "first": "Noel E.",
                    "initial": "N.E.",
                    "last": "Sam"
                },
                {
                    "first": "Faruk",
                    "initial": "F.",
                    "last": "Sinangil"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Pancera"
                },
                {
                    "first": "Yang",
                    "initial": "Y.",
                    "last": "Yongping"
                },
                {
                    "first": "Baoshan",
                    "initial": "B.",
                    "last": "Zhang"
                },
                {
                    "first": "Jiang",
                    "initial": "J.",
                    "last": "Zhu"
                },
                {
                    "first": "Peter D.",
                    "initial": "P.D.",
                    "last": "Kwong"
                },
                {
                    "first": "Sijy",
                    "initial": "S.",
                    "last": "O'Dell"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Mascola"
                },
                {
                    "first": "Lan",
                    "initial": "L.",
                    "last": "Wu"
                },
                {
                    "first": "Gary J.",
                    "initial": "G.J.",
                    "last": "Nabel"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Phogat"
                },
                {
                    "first": "Michael S.",
                    "initial": "M.S.",
                    "last": "Seaman"
                },
                {
                    "first": "John F.",
                    "initial": "J.F.",
                    "last": "Whitesides"
                },
                {
                    "first": "M. Anthony",
                    "initial": "M.A.",
                    "last": "Moody"
                },
                {
                    "first": "Garnett",
                    "initial": "G.",
                    "last": "Kelsoe"
                },
                {
                    "first": "Xinzhen",
                    "initial": "X.",
                    "last": "Yang"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Sodroski"
                },
                {
                    "first": "George M.",
                    "initial": "G.M.",
                    "last": "Shaw"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Montefiori"
                },
                {
                    "first": "Thomas B.",
                    "initial": "T.B.",
                    "last": "Kepler"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                },
                {
                    "first": "S. Munir",
                    "initial": "S.M.",
                    "last": "Alam"
                },
                {
                    "first": "Hua Xin",
                    "initial": "H.X.",
                    "last": "Liao"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                }
            ],
            "doi": "10.1128/JVI.05045-11",
            "firstpage": "9998",
            "issn": "0022538X",
            "lastpage": "10009",
            "pmid": "21795340",
            "pub_year": 2011,
            "title": "Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors",
            "volume": "85"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Morgane",
                    "initial": "M.",
                    "last": "Rolland"
                },
                {
                    "first": "Paul T.",
                    "initial": "P.T.",
                    "last": "Edlefsen"
                },
                {
                    "first": "Brendan B.",
                    "initial": "B.B.",
                    "last": "Larsen"
                },
                {
                    "first": "Sodsai",
                    "initial": "S.",
                    "last": "Tovanabutra"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Sanders-Buell"
                },
                {
                    "first": "Tomer",
                    "initial": "T.",
                    "last": "Hertz"
                },
                {
                    "first": "Allan C.",
                    "initial": "A.C.",
                    "last": "Decamp"
                },
                {
                    "first": "Chris",
                    "initial": "C.",
                    "last": "Carrico"
                },
                {
                    "first": "Sergey",
                    "initial": "S.",
                    "last": "Menis"
                },
                {
                    "first": "Craig A.",
                    "initial": "C.A.",
                    "last": "Magaret"
                },
                {
                    "first": "Hasan",
                    "initial": "H.",
                    "last": "Ahmed"
                },
                {
                    "first": "Michal",
                    "initial": "M.",
                    "last": "Juraska"
                },
                {
                    "first": "Lennie",
                    "initial": "L.",
                    "last": "Chen"
                },
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Konopa"
                },
                {
                    "first": "Snehal",
                    "initial": "S.",
                    "last": "Nariya"
                },
                {
                    "first": "Julia N.",
                    "initial": "J.N.",
                    "last": "Stoddard"
                },
                {
                    "first": "Kim",
                    "initial": "K.",
                    "last": "Wong"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Zhao"
                },
                {
                    "first": "Wenjie",
                    "initial": "W.",
                    "last": "Deng"
                },
                {
                    "first": "Brandon S.",
                    "initial": "B.S.",
                    "last": "Maust"
                },
                {
                    "first": "Meera",
                    "initial": "M.",
                    "last": "Bose"
                },
                {
                    "first": "Shana",
                    "initial": "S.",
                    "last": "Howell"
                },
                {
                    "first": "Adam",
                    "initial": "A.",
                    "last": "Bates"
                },
                {
                    "first": "Michelle",
                    "initial": "M.",
                    "last": "Lazzaro"
                },
                {
                    "first": "Annemarie",
                    "initial": "A.",
                    "last": "O'Sullivan"
                },
                {
                    "first": "Esther",
                    "initial": "E.",
                    "last": "Lei"
                },
                {
                    "first": "Andrea",
                    "initial": "A.",
                    "last": "Bradfield"
                },
                {
                    "first": "Grace",
                    "initial": "G.",
                    "last": "Ibitamuno"
                },
                {
                    "first": "Vatcharain",
                    "initial": "V.",
                    "last": "Assawadarachai"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "O'Connell"
                },
                {
                    "first": "Mark S.",
                    "initial": "M.S.",
                    "last": "Desouza"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Merlin L.",
                    "initial": "M.L.",
                    "last": "Robb"
                },
                {
                    "first": "Jason S.",
                    "initial": "J.S.",
                    "last": "McLellan"
                },
                {
                    "first": "Ivelin",
                    "initial": "I.",
                    "last": "Georgiev"
                },
                {
                    "first": "Peter D.",
                    "initial": "P.D.",
                    "last": "Kwong"
                },
                {
                    "first": "Jonathan M.",
                    "initial": "J.M.",
                    "last": "Carlson"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "William R.",
                    "initial": "W.R.",
                    "last": "Schief"
                },
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "Gilbert"
                },
                {
                    "first": "James I.",
                    "initial": "J.I.",
                    "last": "Mullins"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                }
            ],
            "doi": "10.1038/nature11519",
            "firstpage": "417",
            "issn": "00280836",
            "lastpage": "420",
            "pmid": "22960785",
            "pub_year": 2012,
            "title": "Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2",
            "volume": "490"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Zolla-Pazner"
                },
                {
                    "first": "Rebecca",
                    "initial": "R.",
                    "last": "Powell"
                },
                {
                    "first": "Sara",
                    "initial": "S.",
                    "last": "Yahyaei"
                },
                {
                    "first": "Constance",
                    "initial": "C.",
                    "last": "Williams"
                },
                {
                    "first": "Xunqing",
                    "initial": "X.",
                    "last": "Jiang"
                },
                {
                    "first": "Wei",
                    "initial": "W.",
                    "last": "Li"
                },
                {
                    "first": "Shan",
                    "initial": "S.",
                    "last": "Lu"
                },
                {
                    "first": "Shixia",
                    "initial": "S.",
                    "last": "Wang"
                },
                {
                    "first": "Chitra",
                    "initial": "C.",
                    "last": "Upadhyay"
                },
                {
                    "first": "Catarina E.",
                    "initial": "C.E.",
                    "last": "Hioe"
                },
                {
                    "first": "Max",
                    "initial": "M.",
                    "last": "Totrov"
                },
                {
                    "first": "Xiangpeng",
                    "initial": "X.",
                    "last": "Kong"
                }
            ],
            "doi": "10.1128/JVI.01403-16",
            "firstpage": "10993",
            "issn": "0022538X",
            "lastpage": "11006",
            "pmid": "27630234",
            "pub_year": 2016,
            "title": "Rationally designed vaccines targeting the V2 region of HIV-1 gp120 Induce a focused, cross-clade-reactive, biologically functional antibody response",
            "volume": "90"
        },
        "b0075": {
            "authors": [
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Montefiori"
                },
                {
                    "first": "Chitraporn",
                    "initial": "C.",
                    "last": "Karnasuta"
                },
                {
                    "first": "Ying",
                    "initial": "Y.",
                    "last": "Huang"
                },
                {
                    "first": "Hasan",
                    "initial": "H.",
                    "last": "Ahmed"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Gilbert"
                },
                {
                    "first": "Mark S.",
                    "initial": "M.S.",
                    "last": "De Souza"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "McLinden"
                },
                {
                    "first": "Sodsai",
                    "initial": "S.",
                    "last": "Tovanabutra"
                },
                {
                    "first": "Agnes",
                    "initial": "A.",
                    "last": "Laurence-Chenine"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Sanders-Buell"
                },
                {
                    "first": "M. Anthony",
                    "initial": "M.A.",
                    "last": "Moody"
                },
                {
                    "first": "Mattia",
                    "initial": "M.",
                    "last": "Bonsignori"
                },
                {
                    "first": "Christina",
                    "initial": "C.",
                    "last": "Ochsenbauer"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Kappes"
                },
                {
                    "first": "Haili",
                    "initial": "H.",
                    "last": "Tang"
                },
                {
                    "first": "Kelli",
                    "initial": "K.",
                    "last": "Greene"
                },
                {
                    "first": "Hongmei",
                    "initial": "H.",
                    "last": "Gao"
                },
                {
                    "first": "Celia C.",
                    "initial": "C.C.",
                    "last": "Labranche"
                },
                {
                    "first": "Charla",
                    "initial": "C.",
                    "last": "Andrews"
                },
                {
                    "first": "Victoria R.",
                    "initial": "V.R.",
                    "last": "Polonis"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Jaranit",
                    "initial": "J.",
                    "last": "Kaewkungwal"
                },
                {
                    "first": "Steve G.",
                    "initial": "S.G.",
                    "last": "Self"
                },
                {
                    "first": "Phillip W.",
                    "initial": "P.W.",
                    "last": "Berman"
                },
                {
                    "first": "Donald",
                    "initial": "D.",
                    "last": "Francis"
                },
                {
                    "first": "Faruk",
                    "initial": "F.",
                    "last": "Sinangil"
                },
                {
                    "first": "Carter",
                    "initial": "C.",
                    "last": "Lee"
                },
                {
                    "first": "Jim",
                    "initial": "J.",
                    "last": "Tartaglia"
                },
                {
                    "first": "Merlin L.",
                    "initial": "M.L.",
                    "last": "Robb"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                }
            ],
            "doi": "10.1093/infdis/jis367",
            "firstpage": "431",
            "issn": "00221899",
            "lastpage": "441",
            "pmid": "22634875",
            "pub_year": 2012,
            "title": "Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials",
            "volume": "206"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Hua Xin",
                    "initial": "H.X.",
                    "last": "Liao"
                },
                {
                    "first": "Marc C.",
                    "initial": "M.C.",
                    "last": "Levesque"
                },
                {
                    "first": "Ashleigh",
                    "initial": "A.",
                    "last": "Nagel"
                },
                {
                    "first": "Ashlyn",
                    "initial": "A.",
                    "last": "Dixon"
                },
                {
                    "first": "Ruijun",
                    "initial": "R.",
                    "last": "Zhang"
                },
                {
                    "first": "Emmanuel",
                    "initial": "E.",
                    "last": "Walter"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Parks"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Whitesides"
                },
                {
                    "first": "Dawn J.",
                    "initial": "D.J.",
                    "last": "Marshall"
                },
                {
                    "first": "Kwan Ki",
                    "initial": "K.K.",
                    "last": "Hwang"
                },
                {
                    "first": "Yi",
                    "initial": "Y.",
                    "last": "Yang"
                },
                {
                    "first": "Xi",
                    "initial": "X.",
                    "last": "Chen"
                },
                {
                    "first": "Feng",
                    "initial": "F.",
                    "last": "Gao"
                },
                {
                    "first": "Supriya",
                    "initial": "S.",
                    "last": "Munshaw"
                },
                {
                    "first": "Thomas B.",
                    "initial": "T.B.",
                    "last": "Kepler"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Denny"
                },
                {
                    "first": "M. Anthony",
                    "initial": "M.A.",
                    "last": "Moody"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                }
            ],
            "doi": "10.1016/j.jviromet.2009.02.014",
            "firstpage": "171",
            "issn": "01660934",
            "lastpage": "179",
            "pmid": "19428587",
            "pub_year": 2009,
            "title": "High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies",
            "volume": "158"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Thorsten U.",
                    "initial": "T.U.",
                    "last": "Vogel"
                },
                {
                    "first": "Lucian",
                    "initial": "L.",
                    "last": "Visan"
                },
                {
                    "first": "Belma",
                    "initial": "B.",
                    "last": "Ljutic"
                },
                {
                    "first": "Beata",
                    "initial": "B.",
                    "last": "Gajewska"
                },
                {
                    "first": "Judy",
                    "initial": "J.",
                    "last": "Caterini"
                },
                {
                    "first": "Danielle",
                    "initial": "D.",
                    "last": "Salha"
                },
                {
                    "first": "Tao",
                    "initial": "T.",
                    "last": "Wen"
                },
                {
                    "first": "Liwei",
                    "initial": "L.",
                    "last": "He"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Parrington"
                },
                {
                    "first": "Shi Xian",
                    "initial": "S.X.",
                    "last": "Cao"
                },
                {
                    "first": "Bryan",
                    "initial": "B.",
                    "last": "McNeil"
                },
                {
                    "first": "Devender",
                    "initial": "D.",
                    "last": "Sandhu"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Scollard"
                },
                {
                    "first": "Linong",
                    "initial": "L.",
                    "last": "Zhang"
                },
                {
                    "first": "Bill",
                    "initial": "B.",
                    "last": "Bradley"
                },
                {
                    "first": "Mei",
                    "initial": "M.",
                    "last": "Tang"
                },
                {
                    "first": "Corey",
                    "initial": "C.",
                    "last": "Lovitt"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Oomen"
                },
                {
                    "first": "Pamela",
                    "initial": "P.",
                    "last": "Dunn"
                },
                {
                    "first": "Jim",
                    "initial": "J.",
                    "last": "Tartaglia"
                },
                {
                    "first": "Neil L.",
                    "initial": "N.L.",
                    "last": "Berinstein"
                }
            ],
            "doi": "10.1097/CJI.0b013e3181eccc87",
            "firstpage": "743",
            "issn": "15249557",
            "lastpage": "758",
            "pmid": "20842062",
            "pub_year": 2010,
            "title": "Preclinical qualification of a new multi-antigen candidate vaccine for metastatic melanoma",
            "volume": "33"
        },
        "b0090": null,
        "b0095": {
            "authors": [
                {
                    "first": "Nicos",
                    "initial": "N.",
                    "last": "Karasavvas"
                },
                {
                    "first": "Erik",
                    "initial": "E.",
                    "last": "Billings"
                },
                {
                    "first": "Mangala",
                    "initial": "M.",
                    "last": "Rao"
                },
                {
                    "first": "Constance",
                    "initial": "C.",
                    "last": "Williams"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Zolla-Pazner"
                },
                {
                    "first": "Robert T.",
                    "initial": "R.T.",
                    "last": "Bailer"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Koup"
                },
                {
                    "first": "Sirinan",
                    "initial": "S.",
                    "last": "Madnote"
                },
                {
                    "first": "Duangnapa",
                    "initial": "D.",
                    "last": "Arworn"
                },
                {
                    "first": "Xiaoying",
                    "initial": "X.",
                    "last": "Shen"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                },
                {
                    "first": "Jeffrey R.",
                    "initial": "J.R.",
                    "last": "Currier"
                },
                {
                    "first": "Mike",
                    "initial": "M.",
                    "last": "Jiang"
                },
                {
                    "first": "Craig",
                    "initial": "C.",
                    "last": "Magaret"
                },
                {
                    "first": "Charla",
                    "initial": "C.",
                    "last": "Andrews"
                },
                {
                    "first": "Raphael",
                    "initial": "R.",
                    "last": "Gottardo"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Gilbert"
                },
                {
                    "first": "Timothy J.",
                    "initial": "T.J.",
                    "last": "Cardozo"
                },
                {
                    "first": "Supachai",
                    "initial": "S.",
                    "last": "Rerks-Ngarm"
                },
                {
                    "first": "Sorachai",
                    "initial": "S.",
                    "last": "Nitayaphan"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "Jaranit",
                    "initial": "J.",
                    "last": "Kaewkungwal"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Paris"
                },
                {
                    "first": "Kelli",
                    "initial": "K.",
                    "last": "Greene"
                },
                {
                    "first": "Hongmei",
                    "initial": "H.",
                    "last": "Gao"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Gurunathan"
                },
                {
                    "first": "Jim",
                    "initial": "J.",
                    "last": "Tartaglia"
                },
                {
                    "first": "Faruk",
                    "initial": "F.",
                    "last": "Sinangil"
                },
                {
                    "first": "Bette T.",
                    "initial": "B.T.",
                    "last": "Korber"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Montefiori"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Mascola"
                },
                {
                    "first": "Merlin L.",
                    "initial": "M.L.",
                    "last": "Robb"
                },
                {
                    "first": "Barton F.",
                    "initial": "B.F.",
                    "last": "Haynes"
                },
                {
                    "first": "Viseth",
                    "initial": "V.",
                    "last": "Ngauy"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                },
                {
                    "first": "Mark S.",
                    "initial": "M.S.",
                    "last": "De Souza"
                }
            ],
            "doi": "10.1089/aid.2012.0103",
            "firstpage": "1444",
            "issn": "08892229",
            "lastpage": "1457",
            "pmid": "23035746",
            "pub_year": 2012,
            "title": "The thai phase III HIV type 1 vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120",
            "volume": "28"
        },
        "b0100": null,
        "b0105": {
            "authors": [
                {
                    "first": "C. R.",
                    "initial": "C.R.",
                    "last": "Lambeth"
                },
                {
                    "first": "L. J.",
                    "initial": "L.J.",
                    "last": "White"
                },
                {
                    "first": "R. E.",
                    "initial": "R.E.",
                    "last": "Johnston"
                },
                {
                    "first": "A. M.",
                    "initial": "A.M.",
                    "last": "De Silva"
                }
            ],
            "doi": "10.1128/JCM.43.7.3267-3272.2005",
            "firstpage": "3267",
            "issn": "00951137",
            "lastpage": "3272",
            "pmid": "16000446",
            "pub_year": 2005,
            "title": "Flow cytometry-based assay for titrating dengue virus",
            "volume": "43"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Irina V.",
                    "initial": "I.V.",
                    "last": "Gates"
                },
                {
                    "first": "Yuhua",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Cindy",
                    "initial": "C.",
                    "last": "Shambaugh"
                },
                {
                    "first": "Meredith A.",
                    "initial": "M.A.",
                    "last": "Bauman"
                },
                {
                    "first": "Charles",
                    "initial": "C.",
                    "last": "Tan"
                },
                {
                    "first": "Jean Luc",
                    "initial": "J.L.",
                    "last": "Bodmer"
                }
            ],
            "doi": "10.1128/AEM.02006-08",
            "firstpage": "2027",
            "issn": "00992240",
            "lastpage": "2036",
            "pmid": "19201967",
            "pub_year": 2009,
            "title": "Quantitative measurement of varicella-zoster virus infection by semiautomated flow cytometry",
            "volume": "75"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Boyan",
                    "initial": "B.",
                    "last": "Grigorov"
                },
                {
                    "first": "Jessica",
                    "initial": "J.",
                    "last": "Rabilloud"
                },
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Lawrence"
                },
                {
                    "first": "Denis",
                    "initial": "D.",
                    "last": "Gerlier"
                }
            ],
            "doi": "10.1371/journal.pone.0024135",
            "issn": "19326203",
            "pmid": "21915289",
            "pub_year": 2011,
            "title": "Rapid titration of measles and other viruses: Optimization with determination of replication cycle length",
            "volume": "6"
        },
        "b0120": {
            "authors": [
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Du"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Grover"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Ramanan"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Litwin"
                }
            ],
            "doi": "10.1111/ijlh.12344",
            "firstpage": "3",
            "issn": "17515521",
            "lastpage": "10",
            "pmid": "25976954",
            "pub_year": 2015,
            "title": "The evolution of guidelines for the validation of flow cytometric methods",
            "volume": "37"
        }
    },
    "body_text": [
        {
            "endOffset": 17473,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 17472,
                    "startOffset": 17469
                }
            },
            "secId": "s0005",
            "sentence": "In 2009, the phase III clinical trial RV144 (ClinicalTrials.gov number, NCT00223080) in Thailand was the first to demonstrate modest protection from HIV-1 infection, with an estimated vaccine efficacy of 31.2% after the three and a half year trial [1].",
            "startOffset": 17221,
            "title": "Introduction"
        },
        {
            "endOffset": 28884,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "We first conducted experiments to determine the optimal cell type to use in the biological activity assay.",
            "startOffset": 28778,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 32874,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Thus, two cross-clade-reactive mAbs, CH58 and CH23, were selected based on stability monitoring and signal intensity, optimizing the monitoring of two epitopes.",
            "startOffset": 32714,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 30150,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "To detect gp120 on the surface of ALVAC-HIV (vCP2438)-infected cells, a combination of three mAbs isolated from clinical trial participants, CH58, CH23, and CH38, were initially used.",
            "startOffset": 29967,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 28676,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Parallelism (90% significance) was tested using the equivalence test based on ratio of slopes.",
            "startOffset": 28582,
            "title": "RA determination and statistical analysis"
        },
        {
            "endOffset": 23187,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The virus titer was calculated as 50% Tissue Culture Infective Dose (TCID50) by the Spearman and Kaerber method.",
            "startOffset": 23075,
            "title": "Infectious titer assay"
        },
        {
            "endOffset": 41936,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The RA and TCID50 were not affected by storage at 2 \u00b0C to 8 \u00b0C (Fig. 5A) or at 23 \u00b0C to 27 \u00b0C (Fig. 5B) for up to six months and at 38 \u00b0C to 42 \u00b0C for up to one week (Fig. 5C).",
            "startOffset": 41760,
            "title": "Correlation with the infectious titer assay"
        },
        {
            "endOffset": 44721,
            "parents": [],
            "secId": "s0075",
            "sentence": "Selecting an appropriate statistical analysis approach for determining RA was also a crucial step in assay development.",
            "startOffset": 44602,
            "title": "Discussion"
        },
        {
            "endOffset": 45031,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 45030,
                    "startOffset": 45026
                }
            },
            "secId": "s0075",
            "sentence": "The six-point dilution series was established, of which at least four adjacent points are used to calculate RA, as advised by the United States Pharmacopeia (USP) [20].",
            "startOffset": 44863,
            "title": "Discussion"
        },
        {
            "endOffset": 29459,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "HeLa cells exhibited the highest gp120+ cell frequencies, low variability between replicates, and a clear dose-response, and were thus chosen to proceed with assay development.",
            "startOffset": 29283,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 39577,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Repeatability was analyzed using three independent replicates prepared and analyzed by the same analyst on the same day.",
            "startOffset": 39457,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 40651,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The frequency of gp120+p24+ cells in the assay steadily decreased as the length of time the vaccine samples were heat-stressed increased.",
            "startOffset": 40514,
            "title": "Determination of the stability-indicating capacity of the method"
        },
        {
            "endOffset": 34596,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 34595,
                    "startOffset": 34591
                }
            },
            "secId": "s0055",
            "sentence": "Robustness is an indication of an analytical procedure's reliability during normal usage and is investigated by assessing the capacity of the assay to remain unaffected by deliberate variations of assay parameters [18].",
            "startOffset": 34377,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 44601,
            "parents": [],
            "secId": "s0075",
            "sentence": "In addition to cell type, cell seeding, and selection of mAbs for detection, a number of other critical parameters were examined including plate type, cell concentration, staining procedure and flow cytometry acquisition settings, as well as refining the assay dose range (data not shown).",
            "startOffset": 44312,
            "title": "Discussion"
        },
        {
            "endOffset": 34915,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "For example, operator bias during gating of cell populations of interest in flow analysis was investigated.",
            "startOffset": 34808,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 35661,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Another important parameter evaluated during assay development was robustness.",
            "startOffset": 35583,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 35881,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 35880,
                    "startOffset": 35876
                }
            },
            "secId": "s0055",
            "sentence": "Robustness is an indication of an analytical procedure's reliability during normal usage and is investigated by assessing the capacity of the assay to remain unaffected by deliberate variations of assay parameters [18].",
            "startOffset": 35662,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 35980,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "We first identified critical assay parameters by creating a Fishbone (Ishikawa) Diagram (Fig. S2).",
            "startOffset": 35882,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 47638,
            "parents": [],
            "secId": "s0075",
            "sentence": "However, the long term advantages of this powerful technology outweigh this limitation.",
            "startOffset": 47551,
            "title": "Discussion"
        },
        {
            "endOffset": 19620,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 19619,
                    "startOffset": 19614
                },
                "b0045": {
                    "endOffset": 19619,
                    "startOffset": 19614
                }
            },
            "secId": "s0005",
            "sentence": "The non-neutralizing antiviral functions of antibodies against variable regions of gp120 include ADCC, which was shown to correlate with reduced risk of HIV-1 acquisition [8,9].",
            "startOffset": 19443,
            "title": "Introduction"
        },
        {
            "endOffset": 34695,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "We first identified critical assay parameters by creating a Fishbone (Ishikawa) Diagram (Fig. S2).",
            "startOffset": 34597,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 20916,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, this assay does not specifically address the biological effect of the vaccine, i.e. the expression of encoded transgenes.",
            "startOffset": 20786,
            "title": "Introduction"
        },
        {
            "endOffset": 21537,
            "parents": [],
            "secId": "s0005",
            "sentence": "The assay uses the human anti-gp120 mAbs CH58 and CH23 and a commercial mouse anti-p24 mAb to detect transgene expression and quantify the relative activity (RA) of vaccine products.",
            "startOffset": 21355,
            "title": "Introduction"
        },
        {
            "endOffset": 41377,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The assay readout is TCID50, based on the end-point dilution of the virus that produces cytopathic effects in 50% of the cell culture.",
            "startOffset": 41243,
            "title": "Correlation with the infectious titer assay"
        },
        {
            "endOffset": 18336,
            "parents": [],
            "secId": "s0005",
            "sentence": "To test the regimen in a different geographic region and to potentially improve upon the efficacy observed in RV144 by adding an additional boost immunization and using a different adjuvant, the phase I/II clinical trial HVTN100 (NCT02404311) was initiated in the Republic of South Africa where the incidence of HIV infection (predominantly with Clade C) is the highest in the world.",
            "startOffset": 17953,
            "title": "Introduction"
        },
        {
            "endOffset": 20639,
            "parents": [],
            "secId": "s0005",
            "sentence": "Isolation of such cross-reactive and biologically functional mAbs from clinical trial participants suggests their use in development of biological activity-indicating assays.",
            "startOffset": 20465,
            "title": "Introduction"
        },
        {
            "endOffset": 31397,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "After narrowing down to three potential cell lines: HeLa, HEp-2, and Jurkat, the cells were assessed for dose-dependent gp120 expression after infection (Fig. S1).",
            "startOffset": 31234,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 40513,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Samples of ALVAC-HIV (vCP2438) lot# 2014-01 that were heat-stressed at 35 \u00b0C to 39 \u00b0C for up to eight weeks were tested using the biological activity assay.",
            "startOffset": 40357,
            "title": "Determination of the stability-indicating capacity of the method"
        },
        {
            "endOffset": 17952,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 17951,
                    "startOffset": 17948
                }
            },
            "secId": "s0005",
            "sentence": "The prime/boost immunization regimen used the recombinant canarypox vector ALVAC-HIV (vCP1521) that expresses glycoprotein 120 (gp120) of HIV-1 Clade CRF01_AE sequence (which commonly circulates in Thailand) linked to the transmembrane (TM) anchoring portion of gp41 and Gag and Pro of HIV-1 Clade B sequence (Sanofi Pasteur), and AIDSVAX B/E composed of two gp120 recombinant proteins (Clades B and CRF01_AE) adjuvanted with alum (Global Solutions for Infectious Diseases) [1].",
            "startOffset": 17474,
            "title": "Introduction"
        },
        {
            "endOffset": 31233,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Twelve cell lines were assessed based on the following criteria: permissiveness to ALVAC-HIV (vCP2438) infection, ability to express the encoded transgenes, simplicity to culture and harvest, and viability before and after infection.",
            "startOffset": 31000,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 22514,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 22513,
                    "startOffset": 22509
                }
            },
            "secId": "s0015",
            "sentence": "For specificity experiments, an ALVAC vaccine expressing non-HIV genes was used (ALVAC-MA, manufactured by Sanofi Pasteur) [17].",
            "startOffset": 22386,
            "title": "Vaccine constructs"
        },
        {
            "endOffset": 22939,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Samples were then held at 2 \u00b0C to 8 \u00b0C until testing, at which time they were reconstituted.",
            "startOffset": 22847,
            "title": "Generation of stability samples"
        },
        {
            "endOffset": 47550,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 47549,
                    "startOffset": 47545
                }
            },
            "secId": "s0075",
            "sentence": "Validation of complex instruments such as the flow cytometer for use in a QC lab will require upfront investment prior to implementation [24].",
            "startOffset": 47408,
            "title": "Discussion"
        },
        {
            "endOffset": 18816,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 18815,
                    "startOffset": 18812
                }
            },
            "secId": "s0005",
            "sentence": "The trial showed that the vaccine regimen is safe and immunogenic, and the vaccine candidate met pre-specified criteria and proceeded into the pivotal phase IIb/III efficacy trial HVTN702 (NCT02968849) in October 2016 [2].",
            "startOffset": 18594,
            "title": "Introduction"
        },
        {
            "endOffset": 26607,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Then, 200 \u00b5l/well of GlutaMAX DMEM with 10% FBS were added and the plates incubated for 18 \u00b1 3 h at 37 \u00b0C, 5% CO2.",
            "startOffset": 26493,
            "title": "Biological activity assay"
        },
        {
            "endOffset": 39080,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 39079,
                    "startOffset": 39075
                }
            },
            "secId": "s0060",
            "sentence": "The accuracy of an analytical procedure expresses the closeness of agreement between the value measured and the value which is accepted either as a conventional true value or an accepted reference value [18].",
            "startOffset": 38872,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 42164,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Similarly, the slight increases and decreases in TCID50/mL over time reflect typical assay variability.",
            "startOffset": 42061,
            "title": "Correlation with the infectious titer assay"
        },
        {
            "endOffset": 26063,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "HeLa cells were harvested using TrypLE Select (Cat# 12563, Gibco), resuspended in serum-free media (GlutaMAX DMEM), and plated onto 96-well flat-bottom plates at 2x105 cells/well (25 \u00b5l), not earlier than 2 h before infection.",
            "startOffset": 25837,
            "title": "Biological activity assay"
        },
        {
            "endOffset": 34807,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The parameters deemed most likely to affect results were deliberately altered (bold and underlined in Fig. S2).",
            "startOffset": 34696,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 21818,
            "parents": [],
            "secId": "s0005",
            "sentence": "This assay is shown to be not only specific, accurate, precise, stability-indicating, and robust, but also high-throughput, rapid, and suitable for use in a quality control (QC) environment with the potential to become an important test for future clinical trial material testing.",
            "startOffset": 21538,
            "title": "Introduction"
        },
        {
            "endOffset": 27999,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The double positive (gp120+p24+) population was gated as a percentage of total cells (which were selected by FSC-H vs SSC-H, followed by singlets defined from FSC-H vs FSC-A).",
            "startOffset": 27824,
            "title": "Biological activity assay"
        },
        {
            "endOffset": 21204,
            "parents": [],
            "secId": "s0005",
            "sentence": "Thus, a relevant biological activity assay was developed to address this aspect.",
            "startOffset": 21124,
            "title": "Introduction"
        },
        {
            "endOffset": 40768,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "As shown for the 4.1% of human dose, the % gp120+p24+ cells decreased from 22% at T0 to 10% by week eight (Fig. 4A).",
            "startOffset": 40652,
            "title": "Determination of the stability-indicating capacity of the method"
        },
        {
            "endOffset": 43290,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 43289,
                    "startOffset": 43281
                },
                "b0025": {
                    "endOffset": 43289,
                    "startOffset": 43281
                },
                "b0095": {
                    "endOffset": 43289,
                    "startOffset": 43281
                }
            },
            "secId": "s0075",
            "sentence": "This significant attribute is achieved by using a combination of cross-clade-reactive anti-gp120 mAbs isolated from clinical trial participants, which have been shown to bind to clinically relevant epitopes associated with HIV acquisition [4,5,19].",
            "startOffset": 43042,
            "title": "Discussion"
        },
        {
            "endOffset": 43981,
            "parents": [],
            "secId": "s0075",
            "sentence": "A high-throughput flow cytometry screener is employed to obtain quantitative results rapidly.",
            "startOffset": 43888,
            "title": "Discussion"
        },
        {
            "endOffset": 27291,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "To stain the cells, 50 \u00b5l/well of primary antibody solution containing 6 \u03bcg/mL of each mAb CH58, CH23, and anti-p24 (clone Kal-1) were added, and the plates were incubated for 60 min at RT.",
            "startOffset": 27102,
            "title": "Biological activity assay"
        },
        {
            "endOffset": 31574,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "HeLa cells exhibited the highest gp120+ cell frequencies, low variability between replicates, and a clear dose-response, and were thus chosen to proceed with assay development.",
            "startOffset": 31398,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 23331,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "A 10-fold serial dilution of an ALVAC-HIV sample was transferred to the cells.",
            "startOffset": 23253,
            "title": "Infectious titer assay"
        },
        {
            "endOffset": 33257,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The dot plots show that no significant single positive populations (gp120+p24\u2212 or gp120\u2212p24+) were detected, suggesting that infected cells expressed both transgenes (Fig. 1A and 1B).",
            "startOffset": 33074,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 43041,
            "parents": [],
            "secId": "s0075",
            "sentence": "Importantly, the newly developed biological activity assay uses human cells and measures not only successful infection but also proper expression of the encoded HIV antigens, i.e. intactness of biologically relevant epitopes.",
            "startOffset": 42816,
            "title": "Discussion"
        },
        {
            "endOffset": 33875,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The resultant RA value 1.1 was calculated by measuring the horizontal shift between the two parallel lines along the dose axis, and by assigning RA value 1.0 for the RS.",
            "startOffset": 33706,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 38334,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "For such comparison of RAs, first the theoretical RA values were determined, based on multiple measurements of the test sample lot# 2016-01 (100% concentration).",
            "startOffset": 38173,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 27823,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "After washing, the cells were resuspended in 50 \u00b5l/well of 0.1% BSA in dPBS, and analyzed using the iQue Screener and ForeCyt software.",
            "startOffset": 27688,
            "title": "Biological activity assay"
        },
        {
            "endOffset": 30368,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "However, CH38 was then removed as it did not add any additional benefit in detecting gp120 expression or in sensitivity to detect changes in heat-stressed samples (data not shown) compared to using CH58 and CH23 only.",
            "startOffset": 30151,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 34376,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Another important parameter evaluated during assay development was robustness.",
            "startOffset": 34298,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 38872,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "After measuring the RA of each concentration (50%, 100%, 150%) nine times, and plotting the obtained values against the calculated theoretical values, the assay displayed good linearity across the tested range (slope = 1.022, R2 = 0.960) (Fig. 3B).",
            "startOffset": 38624,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 45235,
            "parents": [],
            "secId": "s0075",
            "sentence": "Stringent statistical criteria for parallel line analysis were determined to ensure that the dose-response curves for the RS and test sample are sufficiently linear and parallel to properly calculate RA.",
            "startOffset": 45032,
            "title": "Discussion"
        },
        {
            "endOffset": 29282,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "After narrowing down to three potential cell lines: HeLa, HEp-2, and Jurkat, the cells were assessed for dose-dependent gp120 expression after infection (Fig. S1).",
            "startOffset": 29119,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 30759,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Thus, two cross-clade-reactive mAbs, CH58 and CH23, were selected based on stability monitoring and signal intensity, optimizing the monitoring of two epitopes.",
            "startOffset": 30599,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 32483,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "However, CH38 was then removed as it did not add any additional benefit in detecting gp120 expression or in sensitivity to detect changes in heat-stressed samples (data not shown) compared to using CH58 and CH23 only.",
            "startOffset": 32266,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 43610,
            "parents": [],
            "secId": "s0075",
            "sentence": "Specifically, the current infectious titer assay requires 6 days incubation for formation of quantifiable plaques, while the flow-cytometry based assay requires an overnight incubation for expression of transgenes.",
            "startOffset": 43396,
            "title": "Discussion"
        },
        {
            "endOffset": 48553,
            "parents": [],
            "secId": "s0075",
            "sentence": "Similar principles can be applied to other viral vector vaccines; however, in the absence of relevant mAbs directly derived from vaccinated humans (which is often the case for vaccines in the early development stage), correlation with pre-clinical immunogenicity results or functional assays may be required to support the biological relevance of the measurement.",
            "startOffset": 48190,
            "title": "Discussion"
        },
        {
            "endOffset": 32265,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "To detect gp120 on the surface of ALVAC-HIV (vCP2438)-infected cells, a combination of three mAbs isolated from clinical trial participants, CH58, CH23, and CH38, were initially used.",
            "startOffset": 32082,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 39710,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Intermediate precision was analyzed using nine independent replicates prepared and analyzed by two analysts on three different days.",
            "startOffset": 39578,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 33523,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "When the dose-response of a test sample is plotted beside that of a reference standard (RS), the RA of the test sample is determined by fitting a straight line through at least four adjacent points.",
            "startOffset": 33325,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 42060,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "A difference of 0.1 RA value from T0 is considered insignificant, as the assay has a standard deviation of 0.1 RA (Fig. 1).",
            "startOffset": 41937,
            "title": "Correlation with the infectious titer assay"
        },
        {
            "endOffset": 21354,
            "parents": [],
            "secId": "s0005",
            "sentence": "Here, we describe the development of a flow cytometry-based assay for evaluating biological activity and stability of the ALVAC-HIV (vCP2438) vaccine.",
            "startOffset": 21204,
            "title": "Introduction"
        },
        {
            "endOffset": 43395,
            "parents": [],
            "secId": "s0075",
            "sentence": "In addition, compared to the infectious titer assay the new assay is less cumbersome and time-consuming.",
            "startOffset": 43291,
            "title": "Discussion"
        },
        {
            "endOffset": 36483,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Independent gating of the same set of experimental data by two operators yielded the same RA of 1.2, even though the gates were visibly different (Fig. 2).",
            "startOffset": 36328,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 37351,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Specificity of the assay was confirmed using ALVAC-MA, a similar vector expressing non-HIV genes.",
            "startOffset": 37254,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 30598,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "When CH58 was assessed alone robust detection of gp120 was achieved, however, improved sensitivity to changes in relative potency of heat-stressed samples was observed when CH23 was used in combination with CH58 (data not shown).",
            "startOffset": 30369,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 18593,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 18592,
                    "startOffset": 18587
                },
                "b0015": {
                    "endOffset": 18592,
                    "startOffset": 18587
                }
            },
            "secId": "s0005",
            "sentence": "The HVTN100 trial used ALVAC-HIV (vCP2438) that expresses gp120 of HIV-1 Clade C sequence linked to the TM portion of gp41 and Gag and Pro of HIV-1 Clade B sequence (Sanofi Pasteur) and bivalent recombinant gp120 (Clade C) adjuvanted with MF59 (GSK) [2,3].",
            "startOffset": 18337,
            "title": "Introduction"
        },
        {
            "endOffset": 44311,
            "parents": [],
            "secId": "s0075",
            "sentence": "We optimized numerous assay parameters during development of the biological activity assay.",
            "startOffset": 44220,
            "title": "Discussion"
        },
        {
            "endOffset": 45799,
            "parents": [],
            "secId": "s0075",
            "sentence": "Thus, the selection of the RS vaccine lot is an important factor, as the RA of any test lot will be a reflection of its similarity to that reference lot.",
            "startOffset": 45646,
            "title": "Discussion"
        },
        {
            "endOffset": 35042,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "A template was used for the gating procedure for the biological activity assay, however the gates could be adjusted as needed.",
            "startOffset": 34916,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 36868,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Thus, the biological activity assay is considered to be robust at each step: during cell infection, staining, and flow cytometric analysis.",
            "startOffset": 36729,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 20108,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 20107,
                    "startOffset": 20098
                },
                "b0060": {
                    "endOffset": 20107,
                    "startOffset": 20098
                },
                "b0065": {
                    "endOffset": 20107,
                    "startOffset": 20098
                }
            },
            "secId": "s0005",
            "sentence": "For example, CH58 was isolated from an RV144 trial participant and recognizes V2 conformational epitopes, binding at the position of imputed immune pressure induced by vaccination [9,12,13].",
            "startOffset": 19918,
            "title": "Introduction"
        },
        {
            "endOffset": 23541,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Six vaccine vials were tested for each time point and the geometric mean was calculated.",
            "startOffset": 23453,
            "title": "Infectious titer assay"
        },
        {
            "endOffset": 34201,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "As lot# 2013-01 was used as the positive control (PC) for each assay, data from 55 assays were evaluated and the mean RA of the PC was 1.1 \u00b1 0.1 (standard deviation), with an average relative 95% confidence interval (CI) of 15%, which is well within the acceptable range for cell-based assays that are intrinsically variable.",
            "startOffset": 33876,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 36327,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "A template was used for the gating procedure for the biological activity assay, however the gates could be adjusted as needed.",
            "startOffset": 36201,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 26304,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Serial dilutions (1.54-fold, representing 6.3%, 4.1%, 2.7%, 1.7%, 1.1%, and 0.7% of human dose by volume) were prepared in duplicates for each ALVAC-HIV (vCP2438) sample, including the reference standard (RS) and positive control (PC) lots.",
            "startOffset": 26064,
            "title": "Biological activity assay"
        },
        {
            "endOffset": 45947,
            "parents": [],
            "secId": "s0075",
            "sentence": "Biological activity-indicating assays are also expected to be able to detect changes in vaccine quality under conditions such as temperature stress.",
            "startOffset": 45799,
            "title": "Discussion"
        },
        {
            "endOffset": 47202,
            "parents": [],
            "secId": "s0075",
            "sentence": "The instrument's high dynamic range also removes the need for manual adjustment of cytometer detection settings, and the analysis software allows creation of templates for gating to reduce operator bias and export of .",
            "startOffset": 46984,
            "title": "Discussion"
        },
        {
            "endOffset": 22217,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The vector is a preparation of live attenuated recombinant canarypox-derived virus that expresses HIV-1 gp120 (Clade C ZM96, based on HIV-1 96ZM651) linked to the TM region of gp41, and Gag and Pro (all Clade B, HIV-1 LAI).",
            "startOffset": 21994,
            "title": "Vaccine constructs"
        },
        {
            "endOffset": 42613,
            "parents": [],
            "secId": "s0075",
            "sentence": "We have developed a relevant biological activity assay for characterizing relative activity and stability of ALVAC-HIV vaccines.",
            "startOffset": 42485,
            "title": "Discussion"
        },
        {
            "endOffset": 26703,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Cells were harvested using Cell Dissociation Buffer and transferred to 96-well V-bottom plates.",
            "startOffset": 26608,
            "title": "Biological activity assay"
        },
        {
            "endOffset": 37990,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 37989,
                    "startOffset": 37985
                }
            },
            "secId": "s0060",
            "sentence": "To determine linearity, accuracy, and precision, three concentrations (50%, 100%, and 150% of dose normally used in the assay procedure) of test sample lot# 2016-01 were tested nine times each, as per ICH guidelines [18].",
            "startOffset": 37769,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 41616,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "This lot had a measured RA of 0.6 and a titer of 8.3 \u00d7 106 TCID50/mL at T0 (Fig. 5).",
            "startOffset": 41532,
            "title": "Correlation with the infectious titer assay"
        },
        {
            "endOffset": 38459,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "To this end, nine RA values at the concentration of 100% were generated, resulting in an average RA of 0.8 (data not shown).",
            "startOffset": 38335,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 45645,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 45644,
                    "startOffset": 45640
                }
            },
            "secId": "s0075",
            "sentence": "The USP states that \u201cfor the purpose of the relative comparison of test to standard, the potency of the standard is usually assigned a value of 1 (or 100%)\u201d [20].",
            "startOffset": 45483,
            "title": "Discussion"
        },
        {
            "endOffset": 28436,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "To determine RA, the logarithmic response (parallel-line model) was applied using a minimum of four adjacent (contiguous) dilution points.",
            "startOffset": 28298,
            "title": "RA determination and statistical analysis"
        },
        {
            "endOffset": 39245,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The biological activity assay was found to be accurate, as defined by a mean percent recovery within 80% to 120% at each concentration of the test sample (Table 1).",
            "startOffset": 39081,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 20465,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 20464,
                    "startOffset": 20455
                },
                "b0075": {
                    "endOffset": 20464,
                    "startOffset": 20455
                },
                "b0080": {
                    "endOffset": 20464,
                    "startOffset": 20455
                }
            },
            "secId": "s0005",
            "sentence": "The mAb CH23 was isolated from an RV135 trial participant (phase II trial of ALVAC-HIV (vCP1521) and AIDSVAX B/E) and binds to a V3 linear epitope, neutralizes tier 1 strains, and mediates ADCC [8,15,16].",
            "startOffset": 20261,
            "title": "Introduction"
        },
        {
            "endOffset": 24234,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "HeLa (ATCC# CCL-2) and HEp-2 (ATCC# CCL-23) cells were cultured in GlutaMAX Dulbecco's Minimum Essential Medium (DMEM) (Cat# 10564-011, Gibco/Thermo Fisher Scientific, Waltham, MA, USA) with 10% FBS at 37 \u00b0C, 5% CO2.",
            "startOffset": 24018,
            "title": "Cell line selection and cell seeding procedure comparison"
        },
        {
            "endOffset": 29591,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "To streamline the cell infection procedure and improve assay efficiency, the timing of cell seeding before infection was evaluated.",
            "startOffset": 29460,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 29748,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Infection of adherent cells seeded the day before was compared with the approach of seeding the cells no more than 2 h before infection, before they adhere.",
            "startOffset": 29592,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 48189,
            "parents": [],
            "secId": "s0075",
            "sentence": "The use of mAbs isolated from clinical trial participants to measure the presence of functional epitopes in the expressed HIV antigens significantly increases the clinical relevance of the assay and ensures reliable assessment of vaccine quality and consistency.",
            "startOffset": 47927,
            "title": "Discussion"
        },
        {
            "endOffset": 40097,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Overall, assessment of the assay validity characteristics as defined by ICH guidelines showed that the biological activity assay is specific, linear, accurate, and precise in measuring RA of ALVAC-HIV (vCP2438) vaccines.",
            "startOffset": 39877,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 19917,
            "parents": [],
            "secId": "s0005",
            "sentence": "Such biologically functional anti-gp120 monoclonal antibodies (mAbs) have been isolated from clinical trial participants following ALVAC-HIV (vCP1521) vaccination.",
            "startOffset": 19754,
            "title": "Introduction"
        },
        {
            "endOffset": 25415,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "For cell seeding comparison, HeLa cells were either seeded (a) the day before infection or (b) no more than 2 h before infection.",
            "startOffset": 25286,
            "title": "Cell line selection and cell seeding procedure comparison"
        },
        {
            "endOffset": 33073,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The finalized biological activity assay yields a linear dose-response between % human dose and % gp120+p24+ cells, comprised of six dilution points representing 0.7% to 6.3% of human dose of vaccine.",
            "startOffset": 32874,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 28581,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Linear regression (95% significance) was tested using ANOVA based on pure error separation, with the test for linearity set at 99% significance.",
            "startOffset": 28437,
            "title": "RA determination and statistical analysis"
        },
        {
            "endOffset": 27101,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Cells were blocked with 50 \u00b5l/well of a buffer containing 1% BSA and 5% goat serum (Cat# A1595 and G6767, Millipore-Sigma, Oakville, ON, Canada) in dPBS (Cat# 14190-144, Gibco) for 10 min at RT.",
            "startOffset": 26907,
            "title": "Biological activity assay"
        },
        {
            "endOffset": 42363,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "However, a significant decrease of 0.2 RA was observed at three weeks at 38 \u00b0C to 42 \u00b0C, and the RA continued to drop until eight weeks, which correlates with the infectious titer results (Fig. 5C).",
            "startOffset": 42165,
            "title": "Correlation with the infectious titer assay"
        },
        {
            "endOffset": 25286,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Dose-response curves were plotted using SoftMax (version 5.4.1, Molecular Devices, Sunnyvale, CA, USA).",
            "startOffset": 25183,
            "title": "Cell line selection and cell seeding procedure comparison"
        },
        {
            "endOffset": 42474,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Overall, the biological activity assay provides results that are in agreement with the infectious titer assay.",
            "startOffset": 42364,
            "title": "Correlation with the infectious titer assay"
        },
        {
            "endOffset": 25809,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Cells were then harvested, stained, and analyzed using the procedure described above.",
            "startOffset": 25724,
            "title": "Cell line selection and cell seeding procedure comparison"
        },
        {
            "endOffset": 36728,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Overall, the assessed parameters including cell seeding density, initial infection time, overnight incubation time, and staining incubation times showed that RA determination was not impacted by deliberate changes in execution (data not shown).",
            "startOffset": 36484,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 43838,
            "parents": [],
            "secId": "s0075",
            "sentence": "The geometric mean of six replicate titrations is reported in the infectious titer assay while the lower variability of the flow cytometry assay allows use of duplicate titrations to achieve satisfactory precision and accuracy.",
            "startOffset": 43611,
            "title": "Discussion"
        },
        {
            "endOffset": 24569,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The cells were infected with ALVAC-HIV (vCP2438) at multiplicity of infection (MOI) of 0.15 to 10 in 96-well flat-bottom plates (Cat# 167008, Nunc/Thermo Fisher Scientific, Waltham, MA, USA) for 18 h at 37 \u00b0C, 5% CO2.",
            "startOffset": 24352,
            "title": "Cell line selection and cell seeding procedure comparison"
        },
        {
            "endOffset": 25182,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Cells were analyzed using the iQue Screener high throughput flow cytometer and ForeCyt software (IntelliCyt, Albuquerque, NM, USA).",
            "startOffset": 25051,
            "title": "Cell line selection and cell seeding procedure comparison"
        },
        {
            "endOffset": 32081,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Although comparison of the two methods demonstrated similar frequencies of gp120+ cells (data not shown), the same-day seeding approach reduced assay time by one day and was thus adopted for further assay development.",
            "startOffset": 31864,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 37769,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The lack of detection of p24 and gp120 expression in cells infected with ALVAC-MA demonstrated assay specificity.",
            "startOffset": 37656,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 40916,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "This led to a drop in RA from 0.9 at T0 to 0.8, 0.6, 0.5, and 0.4 for the time points of one, three, five, and eight weeks, respectively (Fig. 4B).",
            "startOffset": 40769,
            "title": "Determination of the stability-indicating capacity of the method"
        },
        {
            "endOffset": 23829,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0040": {
                    "endOffset": 23785,
                    "startOffset": 23777
                },
                "b0045": {
                    "endOffset": 23785,
                    "startOffset": 23777
                },
                "b0060": {
                    "endOffset": 23785,
                    "startOffset": 23777
                },
                "b0075": {
                    "endOffset": 23828,
                    "startOffset": 23821
                },
                "b0080": {
                    "endOffset": 23828,
                    "startOffset": 23821
                }
            },
            "secId": "s0030",
            "sentence": "CH58 and CH38 were isolated from RV144 trial participants [8,9,12] and CH23 from an RV135 participant [15,16].",
            "startOffset": 23719,
            "title": "Monoclonal antibodies"
        },
        {
            "endOffset": 42815,
            "parents": [],
            "secId": "s0075",
            "sentence": "Currently, the infectious titer assay is the quantitative release test for ALVAC-HIV based on calculation of 50% Tissue Culture Infective Dose (TCID50) of the vaccine vector infectivity in avian cells.",
            "startOffset": 42614,
            "title": "Discussion"
        },
        {
            "endOffset": 41242,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Currently, the infectious titer assay is applied as the quantitative release test and stability-indicating assay for ALVAC-HIV.",
            "startOffset": 41115,
            "title": "Correlation with the infectious titer assay"
        },
        {
            "endOffset": 19442,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 19441,
                    "startOffset": 19438
                }
            },
            "secId": "s0005",
            "sentence": "Further analyses showed that IgG antibodies to variable region 3 (V3) of gp120 inversely correlated with infection risk, specifically in vaccine recipients with lower levels of the inhibiting Env-specific IgA antibodies, antibody-dependent cellular cytotoxicity (ADCC) values, or neutralizing antibodies [7].",
            "startOffset": 19134,
            "title": "Introduction"
        },
        {
            "endOffset": 41759,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The RA was calculated by comparison to the RS lot# 2014-01, which had a titer of 19 \u00d7 106 TCID50/mL, and for which the RA was assigned as 1.0.",
            "startOffset": 41617,
            "title": "Correlation with the infectious titer assay"
        },
        {
            "endOffset": 38172,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 38171,
                    "startOffset": 38167
                }
            },
            "secId": "s0060",
            "sentence": "Linearity of an analytical procedure is the ability to obtain test results which are directly proportional to the concentration (in this case, the RA) of analyte in the sample [18].",
            "startOffset": 37991,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 43887,
            "parents": [],
            "secId": "s0075",
            "sentence": "These factors lead to improved assay throughput.",
            "startOffset": 43839,
            "title": "Discussion"
        },
        {
            "endOffset": 23718,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Human anti-gp120 mAbs CH58, CH23, and CH38 were kindly provided by Dr. Barton F. Haynes from Duke University Medical Center, Durham, North Carolina, USA.",
            "startOffset": 23565,
            "title": "Monoclonal antibodies"
        },
        {
            "endOffset": 20785,
            "parents": [],
            "secId": "s0005",
            "sentence": "The infectious titer assay, which assesses viral vaccine vector infectivity, has been used as a quantitative product release assay for ALVAC-HIV.",
            "startOffset": 20640,
            "title": "Introduction"
        },
        {
            "endOffset": 22846,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Lyophilized ALVAC-HIV (vCP2438) was stored at real-time stability conditions of 2 \u00b0C to 8 \u00b0C for three and six months, and accelerated conditions at higher temperatures of 23 \u00b0C to 27 \u00b0C (for one, three, and six months), and 35 \u00b0C to 39 \u00b0C or 38 \u00b0C to 42 \u00b0C (for one, three, five, and eight weeks).",
            "startOffset": 22548,
            "title": "Generation of stability samples"
        },
        {
            "endOffset": 26906,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Cytofix/Cytoperm (Cat# 554722, BD Biosciences, Mississauga, ON, Canada) was added and incubated at 2 \u00b0C to 8 \u00b0C for 20 min after which the cells were washed using PermWash (Cat# 554723, BD Biosciences).",
            "startOffset": 26704,
            "title": "Biological activity assay"
        },
        {
            "endOffset": 41531,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "In order to compare the trending results from the two assays, we evaluated the RA and TCID50 using stability samples of ALVAC-HIV (vCP2438) lot# 2016-02.",
            "startOffset": 41378,
            "title": "Correlation with the infectious titer assay"
        },
        {
            "endOffset": 19753,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 19752,
                    "startOffset": 19745
                },
                "b0055": {
                    "endOffset": 19752,
                    "startOffset": 19745
                }
            },
            "secId": "s0005",
            "sentence": "Follow-up studies showed that the V1- and V2-specific antibodies cross-react with multiple HIV-1 subtypes including Clade C [10,11].",
            "startOffset": 19621,
            "title": "Introduction"
        },
        {
            "endOffset": 37253,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 37138,
                    "startOffset": 37134
                }
            },
            "secId": "s0060",
            "sentence": "To further assess the performance of the biological activity assay, parameters including specificity, linearity, precision, and accuracy were tested according to International Conference on Harmonization (ICH) guidelines [18], using an ALVAC-HIV (vCP2438) vaccine lot# 2016-01, which is considered representative of clinical trial material.",
            "startOffset": 36913,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 35443,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Overall, the assessed parameters including cell seeding density, initial infection time, overnight incubation time, and staining incubation times showed that RA determination was not impacted by deliberate changes in execution (data not shown).",
            "startOffset": 35199,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 39456,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 39455,
                    "startOffset": 39451
                }
            },
            "secId": "s0060",
            "sentence": "Precision expresses the closeness of agreement between a series of measurements obtained from multiple sampling of the same homogeneous sample, conveyed by a sufficiently low coefficient of variation (CV) [18].",
            "startOffset": 39246,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 25723,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "For (b), cells were counted, plated, and infected within 2 h. For both procedures, cells were infected at an MOI of 10 ALVAC-HIV (vCP2438) for 18 h at 37 \u00b0C, 5% CO2.",
            "startOffset": 25558,
            "title": "Cell line selection and cell seeding procedure comparison"
        },
        {
            "endOffset": 23050,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The result of time zero (T0) samples stored at 2 \u00b0C to 8 \u00b0C was used as the baseline value for all conditions.",
            "startOffset": 22940,
            "title": "Generation of stability samples"
        },
        {
            "endOffset": 31706,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "To streamline the cell infection procedure and improve assay efficiency, the timing of cell seeding before infection was evaluated.",
            "startOffset": 31575,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 47407,
            "parents": [],
            "secId": "s0075",
            "sentence": "These factors allow for data acquisition and analysis to be performed in a single day, making the assay suitable for the QC environment.",
            "startOffset": 47271,
            "title": "Discussion"
        },
        {
            "endOffset": 27687,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The cells were then washed, and 100 \u00b5l/well of secondary antibody solution containing 10 \u03bcg/mL each of R-PE conjugated AffiniPure F(ab\u2019)2 fragment goat anti-human IgG (H + L) and Fluorescein (FITC) conjugated AffiniPure F(ab\u2019)2 fragment goat anti-mouse IgG (H + L) (Cat# 109-116-088 and 115-096-072, Jackson ImmunoResearch) were added, and the plates were incubated for 40 min at RT in the dark.",
            "startOffset": 27292,
            "title": "Biological activity assay"
        },
        {
            "endOffset": 25557,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "For (a), cell number was estimated the day of infection by counting two randomly selected wells and the cell count was used to calculate MOI.",
            "startOffset": 25416,
            "title": "Cell line selection and cell seeding procedure comparison"
        },
        {
            "endOffset": 21993,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "ALVAC-HIV (vCP2438) was developed by Sanofi Pasteur and manufactured under contract to IDT Biologika GmbH (Dessau-Rosslau, Germany).",
            "startOffset": 21861,
            "title": "Vaccine constructs"
        },
        {
            "endOffset": 40356,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "There are storage and cold chain requirements for vaccines, and evaluating effects of temperature stress on vaccine stability and biological activity is essential for assuring vaccine quality.",
            "startOffset": 40164,
            "title": "Determination of the stability-indicating capacity of the method"
        },
        {
            "endOffset": 44220,
            "parents": [],
            "secId": "s0075",
            "sentence": "Here, we describe the assessment of key performance attributes of the biological activity assay and demonstrate that the assay is robust, specific, accurate, precise, stability-indicating, and in agreement with the infectious titer assay.",
            "startOffset": 43982,
            "title": "Discussion"
        },
        {
            "endOffset": 35583,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Thus, the biological activity assay is considered to be robust at each step: during cell infection, staining, and flow cytometric analysis.",
            "startOffset": 35444,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 37655,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Cells infected with an equal mixture of ALVAC-HIV (vCP2438) and ALVAC-MA resulted in an RA value that was half of the RA obtained from the cells infected with only ALVAC-HIV (vCP2438) (RA of 0.4 and 0.8, respectively) (Fig. 3A).",
            "startOffset": 37427,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 41069,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Thus, the biological activity assay is stability-indicating, capable of detecting decreases in vaccine biological activity following temperature stress.",
            "startOffset": 40917,
            "title": "Determination of the stability-indicating capacity of the method"
        },
        {
            "endOffset": 46184,
            "parents": [],
            "secId": "s0075",
            "sentence": "Our data show that the new biological activity assay is stability-indicating and capable of detecting changes in RA of vaccines stored at various storage conditions that correlate with the infectious titer assay results (Figs. 4 and 5).",
            "startOffset": 45948,
            "title": "Discussion"
        },
        {
            "endOffset": 22385,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The vector was formulated as a lyophilized vaccine for injection and was reconstituted in 1 mL of sterile 0.4% sodium chloride (NaCl) solution before use in the assay.",
            "startOffset": 22218,
            "title": "Vaccine constructs"
        },
        {
            "endOffset": 36092,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The parameters deemed most likely to affect results were deliberately altered (bold and underlined in Fig. S2).",
            "startOffset": 35981,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 30893,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Supplementary data associated with this article can be found, in the online version, at https://doi.org/10.1016/j.vaccine.2018.07.034.",
            "startOffset": 30759,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 34298,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Such trending data show that the biological activity assay is reproducible with low variability.",
            "startOffset": 34202,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 46490,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 46489,
                    "startOffset": 46482
                },
                "b0110": {
                    "endOffset": 46489,
                    "startOffset": 46482
                },
                "b0115": {
                    "endOffset": 46489,
                    "startOffset": 46482
                }
            },
            "secId": "s0075",
            "sentence": "Similar to our observation that the trending results from the biological activity assay are in agreement with the infectious titer assay, others have previously reported quantification of virus titer using flow cytometry that correlates well with plaque forming assays and infectious titer assays [21\u201323].",
            "startOffset": 46185,
            "title": "Discussion"
        },
        {
            "endOffset": 47270,
            "parents": [],
            "secId": "s0075",
            "sentence": "csv files that can be imported into PLA using a saved import module.",
            "startOffset": 47202,
            "title": "Discussion"
        },
        {
            "endOffset": 31863,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Infection of adherent cells seeded the day before was compared with the approach of seeding the cells no more than 2 h before infection, before they adhere.",
            "startOffset": 31707,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 19133,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 19132,
                    "startOffset": 19127
                },
                "b0025": {
                    "endOffset": 19132,
                    "startOffset": 19127
                },
                "b0030": {
                    "endOffset": 19132,
                    "startOffset": 19127
                }
            },
            "secId": "s0005",
            "sentence": "Immune-correlate analyses on RV144 case-control samples determined that vaccine-induced immunoglobulin G (IgG) antibodies against variable regions 1 and 2 (V1 and V2) of gp120 correlated with reduced risk of HIV infection, while plasma IgA antibodies against Env correlated with increased risk of HIV infection [4\u20136].",
            "startOffset": 18816,
            "title": "Introduction"
        },
        {
            "endOffset": 32713,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "When CH58 was assessed alone robust detection of gp120 was achieved, however, improved sensitivity to changes in relative potency of heat-stressed samples was observed when CH23 was used in combination with CH58 (data not shown).",
            "startOffset": 32484,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 30999,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "We first conducted experiments to determine the optimal cell type to use in the biological activity assay.",
            "startOffset": 30893,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 35198,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Independent gating of the same set of experimental data by two operators yielded the same RA of 1.2, even though the gates were visibly different (Fig. 2).",
            "startOffset": 35043,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 23452,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "After six days of incubation at 37 \u00b0C, 5% CO2 the virus was quantified by microscopic examination of cytopathic effects.",
            "startOffset": 23332,
            "title": "Infectious titer assay"
        },
        {
            "endOffset": 29118,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Twelve cell lines were assessed based on the following criteria: permissiveness to ALVAC-HIV (vCP2438) infection, ability to express the encoded transgenes, simplicity to culture and harvest, and viability before and after infection.",
            "startOffset": 28885,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 45482,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 45481,
                    "startOffset": 45477
                }
            },
            "secId": "s0075",
            "sentence": "As RA is a measure of drug activity obtained by comparing the dose-response of a test sample to the RS, the two analytes should be biologically similar and the test sample can be expected to behave like a concentration or dilution of the RS [20].",
            "startOffset": 45236,
            "title": "Discussion"
        },
        {
            "endOffset": 39876,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The assay was found to be precise in terms of both repeatability (%CV was less than 15% between each replicate; data not shown) and intermediate precision (Table 1).",
            "startOffset": 39711,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 47805,
            "parents": [],
            "secId": "s0075",
            "sentence": "Taken together, we have developed a high-throughput flow cytometry-based in vitro assay to measure biological activity and stability of a viral vector vaccine for HIV.",
            "startOffset": 47638,
            "title": "Discussion"
        },
        {
            "endOffset": 47926,
            "parents": [],
            "secId": "s0075",
            "sentence": "This assay is currently being used for product characterization during the pivotal phase IIb/III clinical trial HVTN702.",
            "startOffset": 47806,
            "title": "Discussion"
        },
        {
            "endOffset": 20260,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 20259,
                    "startOffset": 20253
                },
                "b0070": {
                    "endOffset": 20259,
                    "startOffset": 20253
                }
            },
            "secId": "s0005",
            "sentence": "CH58 was shown to neutralize laboratory adapted (tier 1) HIV-1 strains, and to mediate ADCC and antibody-dependent cellular phagocytosis (ADCP) [9,14].",
            "startOffset": 20109,
            "title": "Introduction"
        },
        {
            "endOffset": 38623,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The theoretical RAs for concentrations of 50% and 150% were calculated using this measured value, multiplying by 0.5 (RA of 0.4) and 1.5 (RA of 1.2), respectively.",
            "startOffset": 38460,
            "title": "Assessment of assay performance attributes"
        },
        {
            "endOffset": 24351,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Jurkat (ATCC# TIB-152) cells were cultured in RPMI 1640 medium (Cat# A1049101, Gibco) with 10% FBS at 37 \u00b0C, 5% CO2.",
            "startOffset": 24235,
            "title": "Cell line selection and cell seeding procedure comparison"
        },
        {
            "endOffset": 33705,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "In the representative example shown in Fig. 1C, all six dilution points were used for both the test sample and RS vaccine lot, resulting in linear and parallel dose-response curves.",
            "startOffset": 33524,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 23252,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Briefly, 3x104 QT35 cells/well were seeded into a 96-well plate.",
            "startOffset": 23188,
            "title": "Infectious titer assay"
        },
        {
            "endOffset": 46983,
            "parents": [],
            "secId": "s0075",
            "sentence": "An additional advantage of our assay is that a 96-well plate can be analyzed in 30 minutes by employing the automated high-throughput flow cytometer iQue Screener.",
            "startOffset": 46820,
            "title": "Discussion"
        },
        {
            "endOffset": 23958,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Mouse anti-p24 mAb (clone Kal-1) was purchased from Dako/Agilent Technologies Canada Inc. (Cat# M0857, Mississauga, ON, Canada).",
            "startOffset": 23830,
            "title": "Monoclonal antibodies"
        },
        {
            "endOffset": 46819,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 46818,
                    "startOffset": 46811
                },
                "b0110": {
                    "endOffset": 46818,
                    "startOffset": 46811
                },
                "b0115": {
                    "endOffset": 46818,
                    "startOffset": 46811
                }
            },
            "secId": "s0075",
            "sentence": "These studies have illustrated the benefits associated with flow cytometry, which include a reduced infection period (from 5 to 12 days to 1 day), higher throughput, reduced variability, application to viruses that do not form clear plaques, and practical advantages such as a less tedious and labor intensive procedure [21\u201323].",
            "startOffset": 46491,
            "title": "Discussion"
        },
        {
            "endOffset": 29966,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Although comparison of the two methods demonstrated similar frequencies of gp120+ cells (data not shown), the same-day seeding approach reduced assay time by one day and was thus adopted for further assay development.",
            "startOffset": 29749,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 36200,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "For example, operator bias during gating of cell populations of interest in flow analysis was investigated.",
            "startOffset": 36093,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 28297,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "The dose-response curve of % human dose vs % gp120+p24+ cells was plotted and the RA of each vaccine sample (relative to the reference standard (RS) lot) was calculated using Parallel Line Assay (PLA, version 2.0, Stegmann Systems GmbH, Rodgau, Germany).",
            "startOffset": 28043,
            "title": "RA determination and statistical analysis"
        },
        {
            "endOffset": 33324,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Parallel line analysis was used to analyze the dose-response data.",
            "startOffset": 33258,
            "title": "Development of the biological activity assay for determination of vaccine relative activity"
        },
        {
            "endOffset": 26492,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "For the initial infection, 25 \u00b5l/well of each dilution were transferred to the plated cells and incubated for 90 min at 37 \u00b0C, 5% CO2 with gentle tapping of the plate every 20 min to mix.",
            "startOffset": 26305,
            "title": "Biological activity assay"
        },
        {
            "endOffset": 44862,
            "parents": [],
            "secId": "s0075",
            "sentence": "By analyzing all available data, the linear portion of the dose-response curve was identified as suitable for RA determination in our assay.",
            "startOffset": 44722,
            "title": "Discussion"
        },
        {
            "endOffset": 21123,
            "parents": [],
            "secId": "s0005",
            "sentence": "Importantly, assessment of transgene expression should include detection of properly expressed antigens with intact epitopes that were shown to generate relevant functional antibodies in vaccine recipients.",
            "startOffset": 20917,
            "title": "Introduction"
        },
        {
            "endOffset": 25050,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Cells were harvested using Cell Dissociation Buffer (Cat#13151-014, Gibco), transferred to 96-well V-bottom plates (Cat# 3894, Corning Costar, Corning, NY, USA), and stained with a mixture of CH58, CH23, and CH38 mAbs at 6 \u00b5g/mL each, for 60 min at room temperature (RT), followed by R-phycoerythrin (R-PE) conjugated AffiniPure F(ab\u2019)2 fragment goat anti-human IgG (H + L) (Cat# 109-116-088, Jackson ImmunoResearch, West Grove, PA, USA) at 10 \u00b5g/mL, for 40 min at RT in the dark.",
            "startOffset": 24570,
            "title": "Cell line selection and cell seeding procedure comparison"
        },
        {
            "endOffset": 37426,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "For the cells infected with ALVAC-MA, an RA value could not be calculated.",
            "startOffset": 37352,
            "title": "Assessment of assay performance attributes"
        }
    ],
    "docId": "S0264410X1831003X",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Daniela",
                "initial": "D.",
                "last": "Damjanovic"
            },
            {
                "email": null,
                "first": "Liwei",
                "initial": "L.",
                "last": "He"
            },
            {
                "email": null,
                "first": "Julie",
                "initial": "J.",
                "last": "Symes"
            },
            {
                "email": null,
                "first": "Beata",
                "initial": "B.",
                "last": "Gajewska"
            },
            {
                "email": null,
                "first": "Ali",
                "initial": "A.",
                "last": "Azizi"
            },
            {
                "email": null,
                "first": "Danielle",
                "initial": "D.",
                "last": "Salha"
            },
            {
                "email": null,
                "first": "Luciano",
                "initial": "L.",
                "last": "Ettorre"
            },
            {
                "email": null,
                "first": "Lidice",
                "initial": "L.",
                "last": "Bernardo-Reyes"
            },
            {
                "email": null,
                "first": "Jin",
                "initial": "J.",
                "last": "Su"
            },
            {
                "email": null,
                "first": "Sanjay",
                "initial": "S.",
                "last": "Phogat"
            },
            {
                "email": "Lucy.Gisonni-Lex@sanofi.com",
                "first": "Lucy",
                "initial": "L.",
                "last": "Gisonni-Lex"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.07.034",
        "firstpage": "5636",
        "issn": "0264410X",
        "keywords": [
            "Canarypox virus",
            "Clinical trial",
            "HIV",
            "Relative activity",
            "Stability",
            "Vaccine"
        ],
        "lastpage": "5644",
        "openaccess": "Full",
        "pub_year": 2018,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "In vitro assessment of biological activity and stability of the ALVAC-HIV vaccine"
    }
}